BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 37236385)

  • 21. Translation of Pre-Clinical Studies into Successful Clinical Trials for Alzheimer's Disease: What are the Roadblocks and How Can They Be Overcome?
    Banik A; Brown RE; Bamburg J; Lahiri DK; Khurana D; Friedland RP; Chen W; Ding Y; Mudher A; Padjen AL; Mukaetova-Ladinska E; Ihara M; Srivastava S; Padma Srivastava MV; Masters CL; Kalaria RN; Anand A
    J Alzheimers Dis; 2015; 47(4):815-43. PubMed ID: 26401762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Developing effective therapeutics for Alzheimer's disease -- emerging mechanisms and actions in translational medicine.
    Zhang C
    Discov Med; 2017 Feb; 23(125):105-111. PubMed ID: 28371613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Symptomatic and Disease-Modifying Therapy Pipeline for Alzheimer's Disease: Towards a Personalized Polypharmacology Patient-Centered Approach.
    Morató X; Pytel V; Jofresa S; Ruiz A; Boada M
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emerging treatments for Alzheimer's disease for non-amyloid and non-tau targets.
    Khan A; Corbett A; Ballard C
    Expert Rev Neurother; 2017 Jul; 17(7):683-695. PubMed ID: 28490260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systems Biology Methods for Alzheimer's Disease Research Toward Molecular Signatures, Subtypes, and Stages and Precision Medicine: Application in Cohort Studies and Trials.
    Castrillo JI; Lista S; Hampel H; Ritchie CW
    Methods Mol Biol; 2018; 1750():31-66. PubMed ID: 29512064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Molecular targeting and translational research for new therapeutic strategies on Alzheimer's disease].
    Takata K
    Yakugaku Zasshi; 2013; 133(12):1389-99. PubMed ID: 24292188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Understanding the link between insulin resistance and Alzheimer's disease: Insights from animal models.
    Lyra E Silva NM; Gonçalves RA; Boehnke SE; Forny-Germano L; Munoz DP; De Felice FG
    Exp Neurol; 2019 Jun; 316():1-11. PubMed ID: 30930096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isotopic N,N-dimethyl leucine tags for absolute quantification of clusterin and apolipoprotein E in Alzheimer's disease.
    Liu Y; Zhang H; Zhong X; Li Z; Zetterberg H; Li L
    J Proteomics; 2022 Apr; 257():104507. PubMed ID: 35124278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Translational animal models for Alzheimer's disease: An Alzheimer's Association Business Consortium Think Tank.
    Vitek MP; Araujo JA; Fossel M; Greenberg BD; Howell GR; Rizzo SJS; Seyfried NT; Tenner AJ; Territo PR; Windisch M; Bain LJ; Ross A; Carrillo MC; Lamb BT; Edelmayer RM
    Alzheimers Dement (N Y); 2020; 6(1):e12114. PubMed ID: 33457489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Precision pharmacology for Alzheimer's disease.
    Hampel H; Vergallo A; Aguilar LF; Benda N; Broich K; Cuello AC; Cummings J; Dubois B; Federoff HJ; Fiandaca M; Genthon R; Haberkamp M; Karran E; Mapstone M; Perry G; Schneider LS; Welikovitch LA; Woodcock J; Baldacci F; Lista S;
    Pharmacol Res; 2018 Apr; 130():331-365. PubMed ID: 29458203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perspectives for multimodal neurochemical and imaging biomarkers in Alzheimer's disease.
    Teipel SJ; Sabri O; Grothe M; Barthel H; Prvulovic D; Buerger K; Bokde AL; Ewers M; Hoffmann W; Hampel H
    J Alzheimers Dis; 2013; 33 Suppl 1():S329-47. PubMed ID: 22735677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
    Sperling RA; Aisen PS; Beckett LA; Bennett DA; Craft S; Fagan AM; Iwatsubo T; Jack CR; Kaye J; Montine TJ; Park DC; Reiman EM; Rowe CC; Siemers E; Stern Y; Yaffe K; Carrillo MC; Thies B; Morrison-Bogorad M; Wagster MV; Phelps CH
    Alzheimers Dement; 2011 May; 7(3):280-92. PubMed ID: 21514248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Animal systems in the development of treatments for Alzheimer's disease: challenges, methods, and implications.
    Sabbagh JJ; Kinney JW; Cummings JL
    Neurobiol Aging; 2013 Jan; 34(1):169-83. PubMed ID: 22464953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mary S. Easton Center of Alzheimer's Disease Research at UCLA: advancing the therapeutic imperative.
    Cummings JL; Ringman J; Metz K
    J Alzheimers Dis; 2010; 19(2):375-88. PubMed ID: 20110588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: A View of the Regulatory Science Qualification Landscape from the Coalition Against Major Diseases CSF Biomarker Team.
    Arnerić SP; Batrla-Utermann R; Beckett L; Bittner T; Blennow K; Carter L; Dean R; Engelborghs S; Genius J; Gordon MF; Hitchcock J; Kaplow J; Luthman J; Meibach R; Raunig D; Romero K; Samtani MN; Savage M; Shaw L; Stephenson D; Umek RM; Vanderstichele H; Willis B; Yule S
    J Alzheimers Dis; 2017; 55(1):19-35. PubMed ID: 27662307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent advances in the application of metabolomics to Alzheimer's Disease.
    Trushina E; Mielke MM
    Biochim Biophys Acta; 2014 Aug; 1842(8):1232-9. PubMed ID: 23816564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathogenesis, therapeutic strategies and biomarker development based on "omics" analysis related to microglia in Alzheimer's disease.
    Gao C; Shen X; Tan Y; Chen S
    J Neuroinflammation; 2022 Sep; 19(1):215. PubMed ID: 36058959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Application of the NIA-AA Research Framework: Towards a Biological Definition of Alzheimer's Disease Using Cerebrospinal Fluid Biomarkers in the AIBL Study.
    Burnham SC; Coloma PM; Li QX; Collins S; Savage G; Laws S; Doecke J; Maruff P; Martins RN; Ames D; Rowe CC; Masters CL; Villemagne VL
    J Prev Alzheimers Dis; 2019; 6(4):248-255. PubMed ID: 31686097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Alzheimer's disease from Auguste Deter to the present : Progress, disappointments and open questions].
    Pantel J
    Z Gerontol Geriatr; 2017 Oct; 50(7):576-587. PubMed ID: 28924872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin Resistance as a Common Link Between Current Alzheimer's Disease Hypotheses.
    Alves SS; Silva-Junior RMPD; Servilha-Menezes G; Homolak J; Šalković-Petrišić M; Garcia-Cairasco N
    J Alzheimers Dis; 2021; 82(1):71-105. PubMed ID: 34024838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.